BioLineRx (BLRX) Receivables - Other (2012 - 2025)
BioLineRx (BLRX) recorded quarterly Receivables - Other of $410000.0 in Q4 2025, down 41.34% quarter-over-quarter from $699000.0 in Q3 2025, and down 72.26% on a YoY basis from $1.5 million in Q4 2024.
BioLineRx (BLRX) Receivables - Other (2012 - 2025) Analysis & Trends
BioLineRx's Receivables - Other history runs 14 years deep, the most recent figure standing at $410000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 72.26% year-over-year to $410000.0; the TTM figure through Dec 2025 stood at $410000.0 (down 72.26% YoY), while the FY2025 annual figure was $410000.0, down 72.26% from the prior year.
- Receivables - Other was $410000.0 for Q4 2025 at BioLineRx, down from $699000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.5 million in Q4 2024 to a low of $128000.0 in Q2 2023.
- Historically, Receivables - Other has averaged $440800.0 across 5 years, with a median of $332500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 412.5% in 2024, then plunged 72.26% in 2025.
- A 5-year view of Receivables - Other shows it stood at $142000.0 in 2021, then jumped by 407.75% to $721000.0 in 2022, then rose by 15.12% to $830000.0 in 2023, then surged by 78.07% to $1.5 million in 2024, then slumped by 72.26% to $410000.0 in 2025.
- The last three Receivables - Other figures came in at $410000.0 (Q4 2025), $699000.0 (Q3 2025), and $203000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 410,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 1.48 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 315,000.00 |
| Sep 30, 2023 | 315,000.00 |